Alivus Life Sciences Limited (BOM:543322)
India · Delayed Price · Currency is INR 1,072.90
+10.35 (0.97%)
At close: Apr 21, 2026
Alivus Life Sciences Market Cap
Alivus Life Sciences has a market cap or net worth of 131.71 billion as of April 21, 2026. Its market cap has increased by 7.02% in one year.
Market Cap
131.71B
Enterprise Value
125.79B
Revenue
25.12B
Ranking
n/a
PE Ratio
24.23
Stock Price
1,072.90
Market Cap Chart
Since August 6, 2021, Alivus Life Sciences's market cap has increased from 91.71B to 131.71B, an increase of 43.62%. That is a compound annual growth rate of 7.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 131.09B | 16.58% |
| Dec 31, 2025 | 112.45B | -6.68% |
| Dec 31, 2024 | 120.50B | 49.68% |
| Dec 29, 2023 | 80.51B | 56.38% |
| Dec 30, 2022 | 51.48B | -33.42% |
| Dec 31, 2021 | 77.32B | -15.69% |
| Aug 6, 2021 | 91.71B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 195.12B |
| Shilpa Medicare | 80.49B |
| Suven Life Sciences | 55.59B |
| Gujarat Themis Biosyn | 34.81B |
| IOL Chemicals and Pharmaceuticals | 26.76B |
| Sai Parenteral's | 21.63B |
| NGL Fine-Chem | 13.78B |
| Bajaj HealthCare | 10.54B |